Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

68.86 +1.30 (+1.92%)
Streaming Delayed Price Updated: 1:19 PM EST, Dec 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
44 45 Next >
News headline image
“Sell In May Effect”: Uncovering Investment Opportunities During Seasonal Weakness ↗
Despite the seasonal weakness that is often associated with the summer months, there are still market opportunities waiting to be uncovered. 
Via Talk Markets
News headline image
P/E Ratio Insights for DexCom ↗
 
Via Benzinga
News headline image
2 Monster Stocks to Buy Without Any Hesitation ↗
These stocks have grown revenue, earnings and share price over the past five years. 
Via The Motley Fool
News headline image
This Company's Non-Invasive Tech Looks To Be Unique In the Market And Can Help People Take Ownership Over Monitoring Their Health ↗
The need for noninvasive healthcare technology that allows people to take ownership and gather more insight into their health became acute when COVID revealed the fragility of the hospital system.  
Via Benzinga
News headline image
3 Medtech Companies with Higher Future Share Prices
The analysts see normalization and growth for the med tech industry and have started picking their favorites for 2023 and beyond. 
Via MarketBeat
News headline image
Elliott Wave Technical Analysis: DexCom Inc ↗
Looking for further upside into wave (C) as we have broken through the confirmation level (green line). 
Via Talk Markets
News headline image
$100 Invested In DexCom 5 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Where DexCom Stands With Analysts ↗
 
Via Benzinga
News headline image
What To Know About Raymond James's Upgrade of DexCom ↗
 
Via Benzinga
News headline image
Stock Market Rally Drifts Lower; Tesla Dives On Margins; ISRG, DHI, LVS Are Winners: Weekly Review ↗
The major indexes saw modest declines, holding in a range. 
Via Investor's Business Daily
News headline image
Diversified Abbott Laboratories Could Reverse And Move Higher
Abbott Laboratories reported a solid quarter driven by gains in the core business that are accelerating as COVID sales decline. 
Via MarketBeat
News headline image
Physician Checks And Latest Script Data Support DexCom Growth Opportunity: Bullish Analyst Upgrades Stock ↗
 
Via Benzinga
News headline image
The Medicare Decision That Propelled Dexcom Stock Closer To A Breakout ↗
Now, 1.5 million more Americans will have access to CGMs, Dexcom said. 
Via Investor's Business Daily
News headline image
P/E Ratio Insights for DexCom ↗
 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years ↗
 
Via Benzinga
News headline image
Analyst Ratings for DexCom ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 17, 2023 ↗
 
Via Benzinga
News headline image
Visa To Rally 15%? Here Are 10 Other Analyst Forecasts For Monday ↗
Raymond James boosted the price target for DexCom, Inc. (NASDAQ: DXCM) from $127 to $138. Raymond James analyst Jayson Bedford upgraded the stock from Outperform to Strong Buy. DexCom shares rose 1.8%... 
Via Benzinga
News headline image
Healthcare Innovation Drives Medical Device Makers To New Highs
Medical products makers Stryker and Boston Scientific are rallying to all-time highs, while sector peer DexCom is forming a constructive base. 
Via MarketBeat
News headline image
Dexcom Commends Decision to Expand CGM Medicare Coverage to Include People With Diabetes Using All Types of Insulin
From Dexcom, Inc.
Via Business Wire
News headline image
2 Stocks That Turned $40,000 Into $1 Million in 10 Years ↗
Are these stocks still good buys today? 
Via The Motley Fool
News headline image
Elliott Wave Technical Analysis: DexCom Inc. - Tuesday, April 11 ↗
We are looking for further upside in wave (C) as we are seeing what appears to be a triangle in wave (B). 
Via Talk Markets
News headline image
1 Stock-Split Stock That's a Surefire April Buy and 1 to Avoid ↗
One stock-split stock is executing flawlessly and seeing its operating margin climb, while another widely held company is flashing warning signs. 
Via The Motley Fool
News headline image
A Nasdaq Bull Market Is Coming: 2 Fantastic Stocks to Buy and Hold ↗
Investing is a long-term game, and both of these companies are thinking that way. 
Via The Motley Fool
News headline image
3 No-Brainer Medical Device Stocks to Buy Right Now ↗
These companies have consistently delivered revenue and EPS gains. 
Via The Motley Fool
News headline image
Dexcom Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023 at 4:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
News headline image
2 Explosive Growth Stocks to Buy in April ↗
These businesses look to be on solid footing even in a difficult operating environment. 
Via The Motley Fool
News headline image
Dexcom Publishes Annual Sustainability Report
From DexCom, Inc.
Via Business Wire
News headline image
2 All-Weather Stocks to Buy Without Hesitation Right Now ↗
Despite near-term economic clouds, long-term investors can still find compelling buying opportunities. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023 ↗
 
Via Benzinga
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
44 45 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.